Nutanix
NTNX · NASDAQ
About NTNX
- Employees
- 7,800
- Headquarters
- San Jose, California
- Listed
- Sep 30, 2016
- Sector
- Information Technology
- Industry
- Software
- Website
- nutanix.com
NTNX key statistics
- Market cap
- 18.27B
- Price-earnings ratio
- 13.06
- Dividend yield
- —
- Average volume
- 2.53M
- Volume
- 956.25K
- Open price
- $67.38
- High today
- $68.39
- Low today
- $66.45
- 52 Week high
- $75.98
- 52 Week low
- $34.01
Nutanix (NTNX) at a glance
As of Oct 20, 2026, Nutanix (NTNX) shares are priced at $68.20, giving the company a market cap of 18.27B and a price-to-earnings ratio of 13.06.
Today the stock has traded between $66.45 and $68.39. The current price is 2.6% above the day's low and 0.3% below its high.
Volume so far is 956.25K shares, below the average of 2.53M shares a day.
Over the past year Nutanix has ranged from $34.01 to $75.98, and now sits 81% of the way up that range.
Nutanix met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q4 FY26 it reported $0.60 per share against an estimate of $0.4949.
The average analyst price target is $78.32, 14.8% above the current price, from 18 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy61.1%
- Hold38.9%
- Sell0.0%
- Low
- $60.28
- Now
- $68.20
- High
- $94.50
NTNX earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 7 of the last 8 quarters, by 20.3% on average.
- Q1 FY25: reported $0.42 per share against an estimate of $0.3166
- Q2 FY25: reported $0.56 per share against an estimate of $0.4787
- Q3 FY25: reported $0.42 per share against an estimate of $0.3875
- Q4 FY25: reported $0.37 per share against an estimate of $0.3314
- Q1 FY26: reported $0.41 per share against an estimate of $0.4171
- Q2 FY26: reported $0.56 per share against an estimate of $0.457
- Q3 FY26: reported $0.47 per share against an estimate of $0.3654
- Q4 FY26: reported $0.60 per share against an estimate of $0.4949
NTNX news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Nutanix Recognized as a Leader in the Gartner® Distributed Hybrid Infrastructure Magic Quadrant™
Transcript: Nutanix Q4 2026 Earnings Conference Call
12 Information Technology Stocks Moving In Wednesday's After-Market Session
- Adam Eckert
Nutanix Tops Estimates in Q4, Shares Jump
- Press releaseGlobe Newswire
Nutanix Reports Fourth Quarter and Fiscal 2026 Financial Results
- Priya Nigam
Nutanix Is Selling Plenty of Software. Growth May Cool as Hardware Stays Tight
- Press releaseNewsfile
Carrier Connect Data Solutions Strengthens Leadership Team with Strategic Corporate Development Appointment
Similar companies
Companies in the same industry as Nutanix
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.